John M. Maraganore
2017
In 2017, John M. Maraganore earned a total compensation of $1.4M as Chief Executive Officer principal executive officer at Alnylam Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $636,748 |
|---|---|
| Salary | $753,548 |
| Other | $27,098 |
| Total | $1,417,394 |
Maraganore received $753.5K in salary, accounting for 53% of the total pay in 2017.
Maraganore also received $636.7K in non-equity incentive plan and $27.1K in other compensation.
Rankings
In 2017, John M. Maraganore's compensation ranked 7,279th out of 14,666 executives tracked by ExecPay. In other words, Maraganore earned more than 50.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,279 out of 14,666 | 50th |
Division Manufacturing | 2,708 out of 5,772 | 53rd |
Major group Chemicals And Allied Products | 883 out of 2,075 | 57th |
Industry group Drugs | 691 out of 1,731 | 60th |
Industry Pharmaceutical Preparations | 543 out of 1,333 | 59th |
Source: SEC filing on March 23, 2018.
Maraganore's colleagues
We found six more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2017.
2017
Manmeet Soni
Alnylam Pharmaceuticals
Chief Financial Officer
2017
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2017
Barry Greene
Alnylam Pharmaceuticals
President
2017
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2017
Michael Mason
Alnylam Pharmaceuticals
Vice President of Finance and Treasurer former principal financial officer
2017
David-Alexandre Gros
Alnylam Pharmaceuticals